Evidence map›Paper›PMID 26290425›Full record

ArticleBMC musculoskeletal disorders2015

Nucleostemin- and Oct 3/4-positive stem/progenitor cells exhibit disparate anatomical and temporal expression during rat Achilles tendon healing.

Eva Runesson, Paul Ackermann, Jón Karlsson, Bengt I Eriksson

Open access · goldAbstract read
In one paragraph

Article in BMC musculoskeletal disorders, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Complete mid-portion rupture of the rat achilles tendon leads to remote and time-mismatched changes in uninjured regions.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Eva RunessonDepartment of Orthopaedics, Lundberg Laboratory for Orthopaedic Research, Institute of Clinical Sciences, University of Gothenburg, Gröna Stråket 12, Sahlgrenska University Hospital, SE-413 45, Gothenburg, Sweden. eva.runesson@gu.se.
Paul AckermannIntegrative Orthopaedic Laboratory, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. paul.ackermann@karolinska.se.
Jón KarlssonDepartment of Orthopaedics, Lundberg Laboratory for Orthopaedic Research, Institute of Clinical Sciences, University of Gothenburg, Gröna Stråket 12, Sahlgrenska University Hospital, SE-413 45, Gothenburg, Sweden. jon.karlsson@telia.com.
Bengt I ErikssonDepartment of Orthopaedics, Lundberg Laboratory for Orthopaedic Research, Institute of Clinical Sciences, University of Gothenburg, Gröna Stråket 12, Sahlgrenska University Hospital, SE-413 45, Gothenburg, Sweden. bengt.eriksson@gu.se.
University of Gothenburg · SEKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe recent discovery of residing tendon stem/progenitor cells has triggered a growing interest in stem cells as a useful tool in tendon repair. Our knowledge of their involvement in naturally healing tendons is, however, sparse. The aim of this study was to identify and determine stem/progenitor cells in relation to different healing phases and regions in a rat model of Achilles tendon rupture.

methodsSurgery was performed to create a mid-tendon rupture on the right Achilles tendon of 24 rats, whereas the left tendon was used as a control. Tendons were harvested at one, two, eight and 17 weeks post-rupture and stained with antibodies specific to stem/progenitor cells (Octamer-binding transcription factor 3/4 (Oct 3/4) and nucleostemin), migrating cells (Dynamin 2 (Dyn 2)) and leukocytes (CD45). A histological examination was performed on sections stained with Alcian blue.

resultsAt one and two weeks post-rupture, a large number of stem/progenitor cells were discovered throughout the tendon. Most of these cells were nucleostemin positive, whereas only a few Oct 3/4-positive cells were found, mainly situated inside the injury region (I region). At eight and 17 weeks, the increment in stem/progenitor cells had diminished to equal that in the control tendons. At all time points, Oct 3/4-positive cells were also found in the connective tissue surrounding the tendon and at the muscle-tendon junction in both ruptured and control tendons and were often seen at the same location as the migration marker, Dyn 2.

conclusionsThe whole length of the Achilles tendon is infiltrated by stem/progenitor cells at early time points after a mid-tendon rupture. However, different stem/progenitor cell populations exhibit varying anatomical and temporal expressions during Achilles tendon healing, suggesting distinct reparative implications. Oct 3/4 may thus act as a more local, migrating stem/progenitor cell involved in injury-site-specific regenerative effects, as compared to the more general proliferative role of nucleostemin-positive stem/progenitor cells.

Indexed as

Achilles TendonAnimalsCarrier ProteinsCell CountCell LineageDynamin IIFemaleGTP-Binding ProteinsLeukocyte Common AntigensLeukocytesNuclear ProteinsOctamer Transcription Factor-3RatsRats, Sprague-DawleyRuptureStem CellsCarrier ProteinsDynamin IIGnl3 protein, ratGTP-Binding ProteinsLeukocyte Common AntigensNuclear ProteinsOctamer Transcription Factor-3Ptprc protein, rat

Identifiers

PMID26290425
PMCPMC4545962
OpenAlexW1795537182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.